TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · IEX Real-Time Price · USD
6.87
-0.05 (-0.79%)
Jul 22, 2024, 10:03 AM EDT - Market open
TScan Therapeutics Employees
TScan Therapeutics had 154 employees as of December 31, 2023. The number of employees increased by 16 or 11.59% compared to the previous year.
Employees
154
Change (1Y)
16
Growth (1Y)
11.59%
Revenue / Employee
$96,182
Profits / Employee
-$628,552
Market Cap
360.79M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 154 | 16 | 11.59% |
Dec 31, 2022 | 138 | 33 | 31.43% |
Dec 31, 2021 | 105 | 47 | 81.03% |
Dec 31, 2020 | 58 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Revance Therapeutics | 597 |
uniQure | 480 |
Talkspace | 472 |
Xeris Biopharma Holdings | 377 |
Sight Sciences | 214 |
Vanda Pharmaceuticals | 203 |
Lexeo Therapeutics | 58 |
Tourmaline Bio | 44 |
TCRX News
- 5 weeks ago - TScan Therapeutics Announces Updates to its Board of Directors - GlobeNewsWire
- 7 weeks ago - TScan Therapeutics Announces Upcoming Presentation at the Jefferies Global Healthcare Conference - GlobeNewsWire
- 7 weeks ago - TScan Therapeutics Receives FDA's Regenerative Medicine Advanced Therapy (RMAT) Designation for its Two Lead TCR-T Therapy Candidates for the Treatment of Heme Malignancies - GlobeNewsWire
- 2 months ago - TScan Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 2 months ago - TScan Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating TCR-T Therapy for the Treatment of Solid Tumors - GlobeNewsWire
- 3 months ago - TScan Therapeutics Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Meeting - GlobeNewsWire
- 3 months ago - TScan Therapeutics Announces Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 3 months ago - TScan Therapeutics Announces Upcoming Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting - GlobeNewsWire